Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Uterine Fibroids: full-pipeline trial registry
2 of 11 indexed Uterine Fibroids trials are currently recruiting.
Corpus placement: #1,577 of 28,707 conditions by registered trial count.
11 US clinical trials · 2 currently recruiting · #1,577 of 28,707 conditions by registered trial count
Uterine Fibroids: 11 US clinical trials tracked, 2 recruiting.
Uterine Fibroids is the subject of 11 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is University of California, San Francisco, running 3 of these trials.
Enrollment posture brief
Registry condition uterine-fibroids
OPEN 2 | RECR 18% | LATE 2 | EARLY 3 | RANK #1577 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome (18% recruiting · 22 trials)
Uterine Fibroids lists 2 open slots (18% of 11 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Uterine Fibroids on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Uterine Fibroids is recruiting below its size-band peers.
2 of 11 indexed trials (18.2%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Uterine Fibroids research.
University of California, San Francisco accounts for 3 of 11 trials (27.3%). 8 distinct sponsors appear on at least one study for this condition label.
-
Most Uterine Fibroids trials plan to enrol fewer than 100 people.
Median target enrolment is 42 among the 11 trials that report a genuine target (sentinel values excluded). 8 of those (72.7%) plan for fewer than 100 participants.
-
Uterine Fibroids research is mostly interventional.
9 interventional and 2 observational studies make up this index (81.8% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
11 total, page 1 of 1
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Sumitomo Pharma Switzerland
NCT05862272
An Open-Label Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Harmony on Fibroid-related Symptoms
Zenchi
NCT07078682
Uterine Leiomyoma Treatment With Radiofrequency Ablation (ULTRA) Registry
University of California, San Francisco
NCT02100904
Effect of Addition of Steroids on Duration of Analgesia
University of California, Los Angeles
NCT04126824
Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids
ObsEva
NCT03070899
Optimal Order of Concurrent Office Hysteroscopy and Endometrial Biopsy
University of South Florida
NCT02472184
Extension Study of Proellex in Women Who Have Previously Completed Study ZPU 003
Repros Therapeutics
NCT00958334
Evaluation of Safety, Pharmacokinetics, and Efficacy of Proellex Administered Vaginally in Women With Uterine Fibroids
Repros Therapeutics
NCT01451424
Biologic Predictors of Leiomyoma Treatment Outcomes
Elizabeth A. Stewart
NCT01936493
Uterine Leiomyoma Treatment With Radiofrequency Ablation
University of California, San Francisco
NCT01840124
Magnetic Resonance Guided Focused Ultrasound for Uterine Fibroids
University of California, San Francisco
NCT01377519
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 2 |
| Phase 3 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Uterine Fibroids records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Uterine Fibroids trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Uterine Fibroids page
11 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Uterine Fibroids trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of California, San Francisco sponsors the most Uterine Fibroids trials on record, review their full trial history before evaluating a specific study. See University of California, San Francisco's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Uterine Fibroids condition card totals 11 registered trials; most-linked intervention Radiofrequency ablation of fibroids; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.